Chemotherapy and Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors

Clinical trial NCT00003144 · COMPLETED

Trial details

NCT number: NCT00003144
Sponsor: NYU Langone Health
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Drug/Agent Toxicity by Tissue/Organ Unspecified Adult Solid Tumor, Protocol Specific

Start date: 1997-08-01
Primary completion: 2001-04-01
Enrollment: 44

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.